Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients—An Italian Single-Center Experience

Safety data regarding BNT162b2 in cancer patients (CPs) are scarce. Herein we report the side effects (SEs), the adverse events (AEs), and the patient-reported outcomes (PROs) following BNT162b2 administration in CPs treated at the San Luigi Gonzaga University Hospital. All CPs who agreed to partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Persano, Irene, Cani, Massimiliano, Del Rio, Benedetta, Ferrari, Giorgia, Garbo, Edoardo, Parlagreco, Elena, Pisano, Chiara, Cetoretta, Valeria, Delcuratolo, Marco Donatello, Turco, Fabio, Audisio, Alessandro, Cecchi, Cristina, Leone, Gianmarco, Napoli, Valerio Maria, Bertaglia, Valentina, Bianco, Valentina, Capelletto, Enrica, D’Amiano, Carmen, Di Maio, Massimo, Gianetta, Martina, Novello, Silvia, Passiglia, Francesco, Scagliotti, Giorgio Vittorio, Bironzo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855735/
https://www.ncbi.nlm.nih.gov/pubmed/36672673
http://dx.doi.org/10.3390/biomedicines11010165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855735/
https://www.ncbi.nlm.nih.gov/pubmed/36672673
http://dx.doi.org/10.3390/biomedicines11010165

Ejemplares similares